GKOS
GKOS
NYSE · Health Care

Glaukos Corp

$180.02
+9.03 (+5.28%)
As of Aug 7, 9:50 PM ET ·
Financial Highlights (FY 2026)
Revenue
522.40M
Net Income
-193,225,248
Gross Margin
78.0%
Profit Margin
-37.0%
Rev Growth
+21.5%
D/E Ratio
0.11
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 78.0% 78.0% 35.4% 35.4%
Operating Margin -39.3% -35.4% 19.0% 20.4%
Profit Margin -37.0% -35.1% 13.1% 14.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 522.40M 429.96M 2.07B 2.02B
Gross Profit 407.32M 335.24M 732.67M 713.05M
Operating Income -205,460,368 -152,192,865 394.63M 412.42M
Net Income -193,225,248 -143,129,813 271.54M 285.63M
Gross Margin 78.0% 78.0% 35.4% 35.4%
Operating Margin -39.3% -35.4% 19.0% 20.4%
Profit Margin -37.0% -35.1% 13.1% 14.2%
Rev Growth +21.5% +21.5% +8.3% +18.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 469.98M 469.98M 2.72B 2.42B
Total Equity 4.44B 4.44B 2.33B 2.21B
D/E Ratio 0.11 0.11 1.17 1.09
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -202,592,424 -158,405,599 494.65M 536.96M
Free Cash Flow 145.62M 243.35M